AU532515B2 - Creación de Inventos y Patentes con Inteligencia Artificial

AU532515B2 – 17alpha-alkyl, 17beta-ol-steroids
– Google Patents

AU532515B2 – 17alpha-alkyl, 17beta-ol-steroids
– Google Patents
17alpha-alkyl, 17beta-ol-steroids

Info

Publication number
AU532515B2

AU532515B2
AU63637/80A
AU6363780A
AU532515B2
AU 532515 B2
AU532515 B2
AU 532515B2
AU 63637/80 A
AU63637/80 A
AU 63637/80A
AU 6363780 A
AU6363780 A
AU 6363780A
AU 532515 B2
AU532515 B2
AU 532515B2
Authority
AU
Australia
Prior art keywords
alkyl
alkenyl
steroids
17alpha
17beta
Prior art date
1979-10-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Ceased

Application number
AU63637/80A
Other versions

AU6363780A
(en

Inventor
Manfred Albring
Dieter Bittler
Annerose Schleusener
Rudolf Wiechert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bayer Pharma AG

Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1979-10-26
Filing date
1980-10-23
Publication date
1983-10-06

1980-10-23
Application filed by Schering AG
filed
Critical
Schering AG

1981-04-30
Publication of AU6363780A
publication
Critical
patent/AU6363780A/en

1983-10-06
Application granted
granted
Critical

1983-10-06
Publication of AU532515B2
publication
Critical
patent/AU532515B2/en

2000-10-23
Anticipated expiration
legal-status
Critical

Status
Ceased
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07J—STEROIDS

C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton

C07J21/005—Ketals

C07J21/006—Ketals at position 3

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07J—STEROIDS

C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane

C07J1/0003—Androstane derivatives

C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta

C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07J—STEROIDS

C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane

C07J1/0003—Androstane derivatives

C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta

C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group

C07J1/0044—Alkenyl derivatives

Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE

Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

Y02P20/00—Technologies relating to chemical industry

Y02P20/50—Improvements relating to the production of bulk chemicals

Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

17 alpha -substituted steroids of the formula wherein R1 is hydrogen, acyl, alkyl, alkenyl, alkyl or alkenyl interrupted by an oxygen atom, cyclopentyl, or tetrahydropyranyl, R2 is alkyl or alkenyl of 2-6 carbon atoms, X is oxygen or the grouping H(OR3) wherein R3 is hydrogen, acyl, alkyl, alkenyl, alkyl or alkenyl interrupted by an oxygen atom, cyclopentyl, or tetrahydropyranyl, upon topical application, display antiandrogenic properties and can be utilized for the treatment of acne, seborrhea, alopecia and hirsutism.

AU63637/80A
1979-10-26
1980-10-23
17alpha-alkyl, 17beta-ol-steroids

Ceased

AU532515B2
(en)

Applications Claiming Priority (2)

Application Number
Priority Date
Filing Date
Title

DE19792943776

DE2943776A1
(en)

1979-10-26
1979-10-26

17 (ALPHA) ALKYLSTEROIDS, THE PREPARATIONS CONTAINING THE SAME, AND METHOD FOR THE PRODUCTION THEREOF

DE2943776

1979-10-26

Publications (2)

Publication Number
Publication Date

AU6363780A

AU6363780A
(en)

1981-04-30

AU532515B2
true

AU532515B2
(en)

1983-10-06

Family
ID=6084722
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

AU63637/80A
Ceased

AU532515B2
(en)

1979-10-26
1980-10-23
17alpha-alkyl, 17beta-ol-steroids

Country Status (23)

Country
Link

US
(4)

US4344941A
(en)

EP
(1)

EP0027961B1
(en)

JP
(1)

JPS5673097A
(en)

AT
(1)

ATE2221T1
(en)

AU
(1)

AU532515B2
(en)

CA
(1)

CA1160216A
(en)

CS
(1)

CS228507B2
(en)

DD
(1)

DD153694A5
(en)

DE
(2)

DE2943776A1
(en)

DK
(1)

DK163002C
(en)

EG
(1)

EG14998A
(en)

ES
(1)

ES8106539A1
(en)

FI
(1)

FI69850C
(en)

GR
(1)

GR71212B
(en)

HU
(1)

HU183237B
(en)

IE
(1)

IE52686B1
(en)

IL
(1)

IL61332A
(en)

NO
(1)

NO154231C
(en)

PL
(1)

PL125169B1
(en)

PT
(1)

PT71842B
(en)

SU
(1)

SU973025A3
(en)

YU
(1)

YU256680A
(en)

ZA
(1)

ZA806565B
(en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

DE2943776A1
(en)

1979-10-26
1981-05-14
Schering Ag Berlin Und Bergkamen, 1000 Berlin

17 (ALPHA) ALKYLSTEROIDS, THE PREPARATIONS CONTAINING THE SAME, AND METHOD FOR THE PRODUCTION THEREOF

DE3115996A1
(en)

1981-04-13
1982-11-04
Schering Ag, 1000 Berlin Und 4619 Bergkamen

17 (ALPHA) -ALKYL-17 (BETA) -HYDROXY-1 (ALPHA) – METHYL-4-ANDROSTEN-3-ONE-.PRODUCTIONS FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS THAT CONTAIN THESE COMPOUNDS

DE3322285A1
(en)

1983-06-18
1984-12-20
Schering AG, 1000 Berlin und 4709 Bergkamen

1-ALKYL-ANDROSTA-1,4-DIEN-3,17-DIONE, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM

US4885289A
(en)

1983-12-12
1989-12-05
Breuer Miklos M
Alteration of character of male beard growth

US6150405A
(en)

1985-07-18
2000-11-21
Proctor; Peter H.
Hair loss treatment with ascorbates

US5728714A
(en)

1985-07-18
1998-03-17
Proctor; Peter H.
Method for treating hair loss using tempo

US5723502A
(en)

1985-07-18
1998-03-03
Proctor; Peter H.
Topical spin trap composition and method

US5716947A
(en)

1985-07-18
1998-02-10
Proctor; Peter H.
Topical doxyl composition and method

US5470876A
(en)

1985-07-18
1995-11-28
Proctor; Peter H.
Topical sod for treating hair loss

US5714510A
(en)

1985-07-18
1998-02-03
Proctor; Peter H.
Topical proxyl composition and method

US5352442A
(en)

1985-07-18
1994-10-04
Proctor Peter H
Topical tempo

US5714482A
(en)

1985-07-18
1998-02-03
Proctor; Peter H.
Topical spin labels and method

US5472687A
(en)

1985-07-18
1995-12-05
Proctor; Peter H.
Topical pyridine N-oxides

US4898694A
(en)

1987-11-25
1990-02-06
Schwartz Arthur G
17-Hydroxy-steroids

DE3824247A1
(en)

1988-07-13
1990-01-18
Schering Ag

NEW ANDROSTAN DERIVATIVES

DE59207073D1
(en)

1991-01-24
1996-10-17
Rheinische Braunkohlenw Ag

Waste treatment methods

US5328686A
(en)

1991-10-30
1994-07-12
Douglas Shander
Treatment of acne or of pseudofolliculitis barbae

ATE218273T1
(en)

1991-11-05
2002-06-15
Gillette Co

CHANGE IN THE SPEED AND TYPE OF HAIR GROWTH

US5364885A
(en)

1992-11-13
1994-11-15
Ahluwalia Gurpreet S
Reduction of hair growth

US5411991A
(en)

1992-12-22
1995-05-02
Shander; Douglas
Method of reducing hair growth employing sulfhydryl active compounds

US6743419B1
(en)

1992-12-22
2004-06-01
The Gillette Company
Method of reducing hair growth employing sulfhydryl active compounds

US5648394A
(en)

1993-05-27
1997-07-15
Boxall; Brian Alfred
Topical composition for inhibiting hair growth

US6414017B2
(en)

1993-05-28
2002-07-02
The Gillette Company
Inhibition of hair growth

US6248751B1
(en)

1993-05-28
2001-06-19
Gurpreet S. Ahluwalia
Inhibition of hair growth

WO1995018821A2
(en)

1994-01-06
1995-07-13
Sri International
Novel antiandrogenic agents and related pharmaceutical compositions and methods of use

US5474763A
(en)

1994-03-11
1995-12-12
Shander; Douglas
Reduction of hair growth

US5468476A
(en)

1994-03-16
1995-11-21
Ahluwalia; Gurpreet S.
Reduction of hair growth

US5455234A
(en)

1994-03-16
1995-10-03
Ahluwalia; Gurpreet S.
Inhibition of hair growth

US5674477A
(en)

1995-02-28
1997-10-07
Ahluwalia; Gurpreet S.
Reduction of hair growth

DE69622154T2
(en)

1995-02-28
2003-02-13
Gillette Co

USE OF ANGIOGENESE SUPPRESSORS TO INHIBIT HAIR GROWTH

US5728736A
(en)

1995-11-29
1998-03-17
Shander; Douglas
Reduction of hair growth

US5652273A
(en)

1995-11-30
1997-07-29
Henry; James
Reduction of hair growth

US6372712B1
(en)

1998-05-22
2002-04-16
The Board Of Trustees Of The Leland Stanford Jr. University
Synthetic bifunctional molecules containing a drug moiety and presenter protein ligand

US6294188B1
(en)

1998-07-09
2001-09-25
Aviana Biopharm Inc.
Methods involving changing the constitutive and stimulated secretions of the local reproductive system of women

US20070129282A1
(en)

1998-11-24
2007-06-07
Ahlem Clarence N
Pharmaceutical treatments and compositions

DE60045751D1
(en)

1999-09-30
2011-04-28
Harbor Biosciences Inc

Therapeutic treatment of androgen receptor-related conditions

US7285109B2
(en)

2003-02-13
2007-10-23
Boston Scientific Scimed, Inc.
Device and method for collapsing an angioplasty balloon

CA2608144C
(en)

2005-04-28
2012-11-13
Proteus Biomedical, Inc.
Pharma-informatics system

EP1945240B1
(en)

2005-09-16
2016-12-28
Raptor Pharmaceutical Inc
Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof

WO2010095940A2
(en)

2009-02-20
2010-08-26
To-Bbb Holding B.V.
Glutathione-based drug delivery system

CN110075069A
(en)

2009-05-06
2019-08-02
实验室护肤股份有限公司
Include activating agent-calcium phosphate granules compound dermal delivery composition and its application

Family Cites Families (5)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

FR1382468A
(en)

1964-01-28
1964-12-18
Spofa Vereinigte Pharma Werke

Process for the preparation of 1-methyl-substituted 3-keto-androstane compounds, and products according to those obtained by the present or similar process

US3391168A
(en)

1965-08-23
1968-07-02
Searle & Co
1, 17-dimethyl-5-androstane-3beta, 17beta-diol and esters thereof

US3705180A
(en)

1971-09-02
1972-12-05
Paul D Klimstra
17-oxygenate-2-alpha-methyl-2-methylen-5 alpha-androstan-3-ones and intermediates

US4039669A
(en)

1975-08-01
1977-08-02
Sterling Drug Inc.
Composition for topical application and use thereof

DE2943776A1
(en)

1979-10-26
1981-05-14
Schering Ag Berlin Und Bergkamen, 1000 Berlin

17 (ALPHA) ALKYLSTEROIDS, THE PREPARATIONS CONTAINING THE SAME, AND METHOD FOR THE PRODUCTION THEREOF

1979

1979-10-26
DE
DE19792943776
patent/DE2943776A1/en
not_active
Withdrawn

1980

1980-09-26
PT
PT71842A
patent/PT71842B/en
unknown

1980-10-07
YU
YU02566/80A
patent/YU256680A/en
unknown

1980-10-08
ES
ES495740A
patent/ES8106539A1/en
not_active
Expired

1980-10-09
SU
SU802989151A
patent/SU973025A3/en
active

1980-10-14
DK
DK434380A
patent/DK163002C/en
not_active
IP Right Cessation

1980-10-16
EP
EP80106289A
patent/EP0027961B1/en
not_active
Expired

1980-10-16
DE
DE8080106289T
patent/DE3061638D1/en
not_active
Expired

1980-10-16
AT
AT80106289T
patent/ATE2221T1/en
not_active
IP Right Cessation

1980-10-20
US
US06/198,383
patent/US4344941A/en
not_active
Expired – Lifetime

1980-10-22
DD
DD80224695A
patent/DD153694A5/en
not_active
IP Right Cessation

1980-10-23
AU
AU63637/80A
patent/AU532515B2/en
not_active
Ceased

1980-10-23
IL
IL61332A
patent/IL61332A/en
not_active
IP Right Cessation

1980-10-23
PL
PL1980227468A
patent/PL125169B1/en
unknown

1980-10-24
ZA
ZA00806565A
patent/ZA806565B/en
unknown

1980-10-24
GR
GR63214A
patent/GR71212B/el
unknown

1980-10-24
FI
FI803342A
patent/FI69850C/en
not_active
IP Right Cessation

1980-10-24
IE
IE2202/80A
patent/IE52686B1/en
not_active
IP Right Cessation

1980-10-24
NO
NO803172A
patent/NO154231C/en
unknown

1980-10-24
HU
HU802577A
patent/HU183237B/en
not_active
IP Right Cessation

1980-10-26
EG
EG651/80A
patent/EG14998A/en
active

1980-10-27
CA
CA000363342A
patent/CA1160216A/en
not_active
Expired

1980-10-27
CS
CS807263A
patent/CS228507B2/en
unknown

1980-10-27
JP
JP14949780A
patent/JPS5673097A/en
active
Granted

1982

1982-05-20
US
US06/380,328
patent/US4456600A/en
not_active
Expired – Lifetime

1984

1984-06-13
US
US06/620,216
patent/US4558041A/en
not_active
Expired – Fee Related

1986

1986-10-14
US
US06/918,231
patent/US4892867A/en
not_active
Expired – Fee Related

Also Published As

Publication number
Publication date

IL61332A0
(en)

1980-12-31

PL125169B1
(en)

1983-04-30

US4892867A
(en)

1990-01-09

EP0027961A1
(en)

1981-05-06

DE3061638D1
(en)

1983-02-17

NO154231C
(en)

1986-08-13

AU6363780A
(en)

1981-04-30

DK163002B
(en)

1992-01-06

PT71842A
(en)

1980-10-01

FI69850C
(en)

1986-05-26

GR71212B
(en)

1983-04-11

DD153694A5
(en)

1982-01-27

SU973025A3
(en)

1982-11-07

ES495740A0
(en)

1981-06-16

YU256680A
(en)

1983-02-28

CA1160216A
(en)

1984-01-10

EG14998A
(en)

1985-06-30

IL61332A
(en)

1985-05-31

CS228507B2
(en)

1984-05-14

PL227468A1
(en)

1981-07-10

ZA806565B
(en)

1981-10-28

DK434380A
(en)

1981-04-27

IE802202L
(en)

1981-04-26

ES8106539A1
(en)

1981-06-16

NO154231B
(en)

1986-05-05

US4344941A
(en)

1982-08-17

DE2943776A1
(en)

1981-05-14

DK163002C
(en)

1992-06-01

JPS5673097A
(en)

1981-06-17

PT71842B
(en)

1981-07-09

EP0027961B1
(en)

1983-01-12

ATE2221T1
(en)

1983-01-15

FI69850B
(en)

1985-12-31

US4456600A
(en)

1984-06-26

JPH0153280B2
(en)

1989-11-13

NO803172L
(en)

1981-04-27

IE52686B1
(en)

1988-01-20

US4558041A
(en)

1985-12-10

HU183237B
(en)

1984-04-28

FI803342L
(en)

1981-04-27

Información de contacto